Home Companies Janssen Biotech

Janssen Biotech

    Random
    Janssen Biotech

    Provention Bio to Develop Two Janssen GI Immunology Candidates

    Janssen Biotech

    J&J Halts Sirukumab Development, Talacotuzumab Trial

    Janssen Biotech

    Janssen to Develop Bispecific Antibodies Based on Zymeworks Platforms in Up-to-$1.4B...

    Janssen Biotech

    Janssen to Codevelop Theravance’s TD-1473 in $1B+ Collaboration

    Janssen Biotech

    Vivus Buys U.S., Canada Rights to Pancreaze from Janssen for $135M

    Janssen Biotech

    Janssen Halts Clinical Studies of Alzheimer’s Candidate

    Janssen Biotech

    J&J/Janssen’s Cilag to Co-Develop argenx’s Cusatuzumab in $1.8B+ Collaboration

    Retinal Disease
    Janssen Biotech

    J&J’s Janssen to Develop MeiraGTx’s Retinal Disease Gene Therapies

    Janssen Biotech

    J&J Innovation Partners with AdoRx Therapeutics on Lung Cancer Treatments

    Janssen Biotech

    JLABS, Children’s National to Open Incubator, Collaborate on BARDA “Innovation Zone”...

    123Page 1 of 3
    Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.